Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group StudyRobert A. Burger, Joel I. Sorosky|Journal of Clinical Oncology|2007Cited by 880